FFAR4 and brain ischemia: Given these safety concerns surrounding GPR40 activation and the limited exploration of GPR120 modulators in cerebral ischemia, this study focuses on evaluating the neuroprotective efficacy of TUG-891—a potent and selective GPR120 agonist—against ischemic brain injury.